北京世桥生物制药

Beijing Shiqiao Biological Pharmaceutical is a specialized pharmaceutical company headquartered in the Shunyi District of Beijing, China. Founded in 2002 and acquired by China Grand Pharmaceutical and Healthcare Holdings in 2015, the company focuses on the research, development, and large-scale manufacturing of high-end generic drugs and innovative formulations. Its core therapeutic strengths lie in cardiovascular medicine, anti-infectives, and gastroenterology, with a significant market presence in injectable medications. The company operates advanced GMP-certified production lines for small volume injections, lyophilized powders, and solid oral dosages. Shiqiao Pharma is recognized for its technical expertise in complex chemical synthesis and drug delivery systems. By maintaining a rigorous quality control system, the firm serves as a key supplier to major hospitals across China.